Paris, France

Michel Goldberg

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Paris, FR (2005)
  • Paris Cedex, FR (2006 - 2010)

Company Filing History:


Years Active: 2005-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michel Goldberg: Innovator in Therapeutic Peptides

Introduction

Michel Goldberg is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work with peptides derived from IL-2. With a total of four patents to his name, Goldberg's research has the potential to impact medical treatments significantly.

Latest Patents

Goldberg's latest patents include a "Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2." This invention relates to new peptides of IL-2 and their derivatives, which are utilized as therapeutic agents. Another notable patent is the "Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2." This invention also focuses on new peptides of IL-2 and their derivatives, emphasizing their therapeutic applications.

Career Highlights

Michel Goldberg is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to the field of microbiology and immunology. His work at this prestigious institution has allowed him to explore and develop innovative therapeutic solutions.

Collaborations

Goldberg has collaborated with notable colleagues, including Jacques Theze and Ralph Eckenberg. These collaborations have likely enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Michel Goldberg's work in the field of therapeutic peptides showcases his dedication to advancing medical science. His patents reflect a commitment to developing innovative solutions that could lead to significant improvements in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…